Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Protein Sciences Will Lease Pfizer Plant

by Rick Mullin
December 10, 2012 | A version of this story appeared in Volume 90, Issue 50

Protein Sciences, a manufacturer of recombinant flu vaccines, plans to make a multi-million-dollar investment in vaccine production at Pfizer’s Pearl River, N.Y., campus. The company will lease an 83,000-sq-ft building at the Pfizer facility to manufacture Flublok, a pandemic flu vaccine that it expects FDA to approve early next year. Wyeth, now part of Pfizer, had also used the plant to make a vaccine. Protein Sciences says it is also studying a manufacturing expansion near its headquarters in Meriden, Conn.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.